EVE Health Group Initiates Pilot Study of Libbo Oral Soluble Film to Treat ED

· smallcaps.com.au

EVE Health launches pilot Libbo ED study (oral soluble film), a key bioequivalence step toward regulatory approval; results expected by end-September. ASX:EVE

EVE Health Group (ASX: EVE) has initiated a pilot clinical study for vardenafil oral soluble film Libbo for the treatment of erectile dysfunction (ED).

The stu...


Read on WOBR AI → · More AI market news · StrategyVerse · Quant Research · WOBR.AI